Summary

The global Point-of-Care HbA1c Test Cartridges market is projected to grow from US$ 470 million in 2025 to US$ 802 million by 2032, at a CAGR of 7.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Point-of-Care HbA1c Test Cartridges are single-use in vitro diagnostic consumables designed for quantitative glycated hemoglobin testing near the patient and used with dedicated or multi-assay point-of-care analyzers. These products typically integrate the reaction reagents, sample handling structure and optical or fluorescence detection interface into a sealed cartridge, cassette or reagent card, enabling HbA1c measurement from a small volume of capillary or venous whole blood within several minutes. Commercial products mainly employ boronate affinity, antibody agglutination and fluorescence immunoassay technologies, with representative sample requirements generally ranging from sub-microliter levels to approximately 5 μL and assay times commonly within about 3–7 minutes. The market is centered on recurring disposable test consumables used in primary care clinics, diabetes specialty clinics, hospital outpatient departments, community health centers, pharmacies and long-term care facilities. Product demand is closely linked to installed point-of-care analyzer platforms, diabetes monitoring frequency, decentralized testing adoption and the ability of healthcare providers to obtain actionable HbA1c results during a single patient visit.
Key Findings
The market is characterized by recurring consumable demand linked to installed HbA1c point-of-care analyzer platforms
Boronate affinity and immunoassay-based cartridge systems represent the principal commercial technology routes
Market Trends
The Point-of-Care HbA1c Test Cartridges market is moving toward faster testing, smaller blood sample requirements, greater automation and broader integration with multi-assay point-of-care platforms. Product development is increasingly focused on simplified sample preparation, closed single-use reagent systems and reduced operator dependence, supporting wider deployment outside central laboratories. Dedicated HbA1c analyzers remain important in diabetes-focused settings, while multi-assay platforms are gaining relevance in primary care and decentralized clinical environments where providers seek to combine HbA1c with renal, lipid, inflammatory or other chronic disease markers on a single analyzer. Standardization and traceability remain central product requirements, with commercial systems increasingly emphasizing alignment with IFCC and NGSP reference frameworks. At the same time, the expansion of Asian manufacturers is increasing the availability of lower-cost cartridge systems, creating a broader price spectrum between premium international brands and competitively priced regional platforms.
Market Dynamics
Drivers
The principal market driver is the continued expansion of the global population requiring long-term diabetes management and periodic HbA1c monitoring. Point-of-care testing enables clinicians to obtain results during the same consultation, reducing dependence on separate laboratory visits and supporting more immediate treatment adjustment. Growth is also supported by wider deployment of HbA1c testing in primary care, community health centers and outpatient diabetes management. The recurring nature of cartridges creates a direct relationship between analyzer placement, testing frequency and consumable demand, while increasing adoption of decentralized chronic disease management further expands the addressable testing base.
Restraints
Market development is constrained by the continued dominance of centralized laboratory HbA1c testing in many healthcare systems, particularly where laboratory infrastructure is mature and reimbursement favors high-throughput testing. Point-of-care cartridges also carry higher per-test costs than some centralized laboratory reagent systems, which can limit adoption in price-sensitive public healthcare settings. Differences in analyzer compatibility and closed-platform consumable designs reduce interchangeability between manufacturers, while quality-control requirements, operator training and regulatory requirements for diagnostic use can increase the cost and complexity of implementation.
Opportunities
The strongest opportunities are concentrated in healthcare systems seeking to decentralize diabetes monitoring and improve patient follow-up. Primary care clinics, community-based chronic disease programs, pharmacies and regional medical centers represent important expansion areas because rapid HbA1c testing can shorten the diagnostic and treatment workflow. Emerging markets also provide substantial headroom as diabetes prevalence rises while laboratory access remains uneven. Multi-assay point-of-care platforms create an additional opportunity by allowing HbA1c cartridges to share installed instruments with other chronic disease tests, improving analyzer utilization and lowering the effective infrastructure cost per test.
Challenges
The industry faces continued pricing pressure as Chinese, Korean and other Asian manufacturers expand international registrations and supply competitively priced cartridges. Manufacturers must maintain analytical consistency across production batches while meeting strict standardization, calibration and quality-control requirements. Closed analyzer-cartridge ecosystems also increase dependence on installed instrument bases, making commercial success partly dependent on analyzer placement, distributor capability and local service infrastructure. In addition, differences in reimbursement, diagnostic regulations and point-of-care testing policies across countries can produce uneven adoption rates and complicate global market expansion.
Industry Chain Analysis
The upstream segment of the Point-of-Care HbA1c Test Cartridges industry includes antibodies, boronate affinity reagents, latex particles, fluorescent labels, buffers, membranes, microfluidic materials, optical components and injection-molded plastic cartridge structures. Manufacturing value is created through reagent formulation, biological material stabilization, precision dispensing, cartridge assembly, calibration, quality control and automated packaging. Because each cartridge must deliver reproducible quantitative results with small whole-blood samples, manufacturing consistency and calibration control are key barriers to entry. Automation capability becomes particularly important at higher volumes, as large POCT manufacturers can operate multi-product reagent and cartridge lines with annual output measured in tens or hundreds of millions of tests across their total diagnostic portfolios.
The midstream segment consists of integrated IVD manufacturers supplying proprietary HbA1c analyzers and recurring single-use consumables, as well as specialized OEM manufacturers producing cartridges for third-party brands. Downstream customers include primary care providers, diabetes clinics, hospital outpatient departments, community health centers, pharmacies and long-term care facilities. The value chain is therefore strongly influenced by installed analyzer bases: instruments create the testing platform, while recurring cartridges generate the majority of long-term consumable demand. Manufacturers with established analyzer placement, regulatory registrations, distribution networks and automated cartridge production generally have stronger recurring revenue visibility than suppliers relying primarily on standalone reagent sales.
Segment Insights
By product type, boronate affinity HbA1c cartridges form one of the most established technology groups because the method can provide rapid quantitative testing with small whole-blood samples and is widely used in dedicated HbA1c point-of-care analyzers. Antibody agglutination systems also maintain an important commercial position, particularly among established international analyzer platforms. Fluorescence immunoassay cartridges are more frequently associated with broader POCT platforms and are increasingly represented among Chinese and other Asian manufacturers. The competitive distinction between these categories is increasingly determined not only by analytical method but also by sample volume, assay time, ease of operation, calibration requirements and platform economics.
By analyzer platform, dedicated HbA1c systems remain important where testing volumes are concentrated around diabetes management, while multi-assay POCT platforms provide broader utilization opportunities in general practice and community medicine. The latter model can reduce dependence on a single test menu because one analyzer supports multiple diagnostic cartridges. As a result, platform breadth, installed-base expansion and consumable attachment rates are becoming increasingly important commercial variables in addition to the analytical performance of individual HbA1c cartridges.
Downstream Market Opportunities
Primary care represents a particularly important downstream opportunity because HbA1c testing can be completed during routine diabetes follow-up and linked directly to treatment decisions. Diabetes specialty clinics and hospital outpatient departments remain core high-frequency testing environments, while community health centers offer meaningful expansion potential in regions where centralized laboratory access is limited. Pharmacy-based testing and long-term care applications remain smaller but provide incremental opportunities for decentralized monitoring. The broader opportunity is shifting from simple substitution of laboratory testing toward integrated chronic disease management, where rapid HbA1c results improve patient workflow and allow healthcare providers to combine testing, consultation and medication adjustment within a single visit.
Regional Insights
North America and Europe represent mature high-value markets characterized by established diabetes management pathways, broad physician-office testing infrastructure and strong penetration of internationally recognized analyzer platforms. These regions generally support higher cartridge pricing, but expansion is moderated by well-developed central laboratory systems and mature installed bases. Japan also maintains a specialized HbA1c point-of-care manufacturing base, with domestic manufacturers serving clinics and small medical institutions through compact dedicated platforms.
Asia-Pacific is increasingly important on both the supply and demand sides. China and South Korea have developed dense clusters of POCT manufacturers with capabilities in fluorescence immunoassay, boronate affinity testing, cartridge automation and OEM manufacturing, while China Taiwan also hosts established cartridge and analyzer suppliers. India and Southeast Asia represent important demand expansion markets as diabetes management infrastructure develops and decentralized testing becomes more accessible. Regional competition is therefore increasingly differentiated between premium international systems with established clinical networks and cost-competitive Asian platforms seeking broader regulatory registration and distribution coverage.
Competitive Landscape Analysis
The competitive landscape combines large diversified diagnostic groups, established POCT specialists and a growing group of Asian cartridge manufacturers. Abbott and Siemens Healthineers represent globally established HbA1c point-of-care platforms with strong installed-base and clinical-channel advantages, while companies such as ACON, Sinocare, SD BIOSENSOR, HORIBA, Nova Biomedical, i-SENS, Wondfo, Getein and Orient Gene contribute significant manufacturing and commercialization capabilities across different regional markets. Specialized manufacturers including Boditech Med, OSANG healthcare, GC Medical Science, EKF Diagnostics, TaiDoc, Apex Biotechnology, Goldsite, BioHermes and other regional producers broaden the competitive field through dedicated technology platforms, OEM manufacturing and lower-cost product positioning. Competition is increasingly shaped by analyzer placement, recurring cartridge consumption, regulatory certification, manufacturing automation, assay standardization and distributor coverage rather than cartridge price alone. OEM relationships are also structurally important, as several internationally marketed HbA1c systems are manufactured by third-party diagnostic producers, making manufacturer-level competition more concentrated than brand-level market visibility may suggest.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Point-of-Care HbA1c Test Cartridges market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Abbott Diagnostics Technologies AS
Siemens Healthcare Diagnostics Inc.
ACON Laboratories, Inc.
Changsha Sinocare Inc.
SD BIOSENSOR, Inc.
HORIBA, Ltd.
Nova Biomedical Corporation
i-SENS, Inc.
Guangzhou Wondfo Biotech Co., Ltd.
Getein Biotech, Inc.
Zhejiang Orient Gene Biotech Co., Ltd.
Zybio Inc.
Boditech Med Inc.
OSANG healthcare Co., Ltd.
GC Medical Science Corporation
EKF-diagnostic GmbH
TaiDoc Technology Corporation
Apex Biotechnology Corp.
Goldsite Diagnostics Inc.
Wuxi BioHermes Bio&Medical Technology Co., Ltd.
Xiamen Biotime Biotechnology Co., Ltd.
Labnovation Technologies, Inc.
AEHEALTH LIMITED
J. Mitra & Co. Pvt. Ltd.
Anbio Xiamen Biotechnology Co., Ltd.
Skyla Corporation
DxGen Corp.
SAKAE Corporation
EMPECS Medical Device Co., Ltd.
EUROLyser Diagnostica GmbH
TASCOM Co., Ltd.
CareforU Co., Ltd.
Dr. Müller Gerätebau GmbH
Nanjing Vazyme Medical Technology Co., Ltd.
Vitrosens Biyoteknoloji A.Ş.
Segment by Type
Boronate Affinity HbA1c Cartridges
Antibody Agglutination HbA1c Cartridges
Fluorescence Immunoassay HbA1c Cartridges
Other
Segment by Analyzer Platform Scope
Dedicated HbA1c Platform Cartridges
Multi-Assay POCT Platform Cartridges
Other
Segment by Application
Primary Care Clinics
Diabetes Specialty Clinics
Hospital Outpatient Departments
Community Health Centers
Pharmacies
Long-Term Care Facilities
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Point-of-Care HbA1c Test Cartridges study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Point-of-Care HbA1c Test Cartridges: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Point-of-Care HbA1c Test Cartridges Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Boronate Affinity HbA1c Cartridges
1.2.3 Antibody Agglutination HbA1c Cartridges
1.2.4 Fluorescence Immunoassay HbA1c Cartridges
1.2.5 Other
1.3 Market Segmentation by Analyzer Platform Scope
1.3.1 Global Point-of-Care HbA1c Test Cartridges Market Size by Analyzer Platform Scope, 2021 vs 2025 vs 2032
1.3.2 Dedicated HbA1c Platform Cartridges
1.3.3 Multi-Assay POCT Platform Cartridges
1.3.4 Other
1.4 Market Segmentation by Application
1.4.1 Global Point-of-Care HbA1c Test Cartridges Market Size by Application, 2021 vs 2025 vs 2032
1.4.2 Primary Care Clinics
1.4.3 Diabetes Specialty Clinics
1.4.4 Hospital Outpatient Departments
1.4.5 Community Health Centers
1.4.6 Pharmacies
1.4.7 Long-Term Care Facilities
1.4.8 Other
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Point-of-Care HbA1c Test Cartridges Revenue Estimates and Forecasts (2021-2032)
2.2 Global Point-of-Care HbA1c Test Cartridges Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Point-of-Care HbA1c Test Cartridges Sales Estimates and Forecasts (2021-2032)
2.4 Global Point-of-Care HbA1c Test Cartridges Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Point-of-Care HbA1c Test Cartridges Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Point-of-Care HbA1c Test Cartridges Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Boronate Affinity HbA1c Cartridges: Market Share by Key Manufacturers
3.5.2 Antibody Agglutination HbA1c Cartridges: Market Share by Key Manufacturers
3.5.3 Fluorescence Immunoassay HbA1c Cartridges: Market Share by Key Manufacturers
3.5.4 Other: Market Share by Key Manufacturers
3.6 Global Point-of-Care HbA1c Test Cartridges Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Point-of-Care HbA1c Test Cartridges Sales Performance by Type
4.1.1 Global Point-of-Care HbA1c Test Cartridges Sales Volume by Type (2021-2032)
4.1.2 Global Point-of-Care HbA1c Test Cartridges Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Point-of-Care HbA1c Test Cartridges Sales Performance by Analyzer Platform Scope
4.2.1 Global Point-of-Care HbA1c Test Cartridges Sales Volume by Analyzer Platform Scope (2021-2032)
4.2.2 Global Point-of-Care HbA1c Test Cartridges Revenue by Analyzer Platform Scope (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Analyzer Platform Scope (2021-2032)
4.3 Product Technology Differentiation
4.4 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.4.1 High-Growth Niches and Adoption Drivers
4.4.2 Profitability Hotspots and Cost Drivers
4.4.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Point-of-Care HbA1c Test Cartridges Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Point-of-Care HbA1c Test Cartridges Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Point-of-Care HbA1c Test Cartridges Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Point-of-Care HbA1c Test Cartridges Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Point-of-Care HbA1c Test Cartridges Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Point-of-Care HbA1c Test Cartridges Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Point-of-Care HbA1c Test Cartridges Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Point-of-Care HbA1c Test Cartridges Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Point-of-Care HbA1c Test Cartridges Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Point-of-Care HbA1c Test Cartridges Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Point-of-Care HbA1c Test Cartridges Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Point-of-Care HbA1c Test Cartridges Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Abbott Diagnostics Technologies AS
11.1.1 Abbott Diagnostics Technologies AS Corporation Information
11.1.2 Abbott Diagnostics Technologies AS Business Overview
11.1.3 Abbott Diagnostics Technologies AS Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.1.4 Abbott Diagnostics Technologies AS Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Abbott Diagnostics Technologies AS Point-of-Care HbA1c Test Cartridges Sales by Product in 2025
11.1.6 Abbott Diagnostics Technologies AS Point-of-Care HbA1c Test Cartridges Sales by Application in 2025
11.1.7 Abbott Diagnostics Technologies AS Point-of-Care HbA1c Test Cartridges Sales by Geographic Area in 2025
11.1.8 Abbott Diagnostics Technologies AS Point-of-Care HbA1c Test Cartridges SWOT Analysis
11.1.9 Abbott Diagnostics Technologies AS Recent Developments
11.2 Siemens Healthcare Diagnostics Inc.
11.2.1 Siemens Healthcare Diagnostics Inc. Corporation Information
11.2.2 Siemens Healthcare Diagnostics Inc. Business Overview
11.2.3 Siemens Healthcare Diagnostics Inc. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.2.4 Siemens Healthcare Diagnostics Inc. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Siemens Healthcare Diagnostics Inc. Point-of-Care HbA1c Test Cartridges Sales by Product in 2025
11.2.6 Siemens Healthcare Diagnostics Inc. Point-of-Care HbA1c Test Cartridges Sales by Application in 2025
11.2.7 Siemens Healthcare Diagnostics Inc. Point-of-Care HbA1c Test Cartridges Sales by Geographic Area in 2025
11.2.8 Siemens Healthcare Diagnostics Inc. Point-of-Care HbA1c Test Cartridges SWOT Analysis
11.2.9 Siemens Healthcare Diagnostics Inc. Recent Developments
11.3 ACON Laboratories, Inc.
11.3.1 ACON Laboratories, Inc. Corporation Information
11.3.2 ACON Laboratories, Inc. Business Overview
11.3.3 ACON Laboratories, Inc. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.3.4 ACON Laboratories, Inc. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 ACON Laboratories, Inc. Point-of-Care HbA1c Test Cartridges Sales by Product in 2025
11.3.6 ACON Laboratories, Inc. Point-of-Care HbA1c Test Cartridges Sales by Application in 2025
11.3.7 ACON Laboratories, Inc. Point-of-Care HbA1c Test Cartridges Sales by Geographic Area in 2025
11.3.8 ACON Laboratories, Inc. Point-of-Care HbA1c Test Cartridges SWOT Analysis
11.3.9 ACON Laboratories, Inc. Recent Developments
11.4 Changsha Sinocare Inc.
11.4.1 Changsha Sinocare Inc. Corporation Information
11.4.2 Changsha Sinocare Inc. Business Overview
11.4.3 Changsha Sinocare Inc. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.4.4 Changsha Sinocare Inc. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Changsha Sinocare Inc. Point-of-Care HbA1c Test Cartridges Sales by Product in 2025
11.4.6 Changsha Sinocare Inc. Point-of-Care HbA1c Test Cartridges Sales by Application in 2025
11.4.7 Changsha Sinocare Inc. Point-of-Care HbA1c Test Cartridges Sales by Geographic Area in 2025
11.4.8 Changsha Sinocare Inc. Point-of-Care HbA1c Test Cartridges SWOT Analysis
11.4.9 Changsha Sinocare Inc. Recent Developments
11.5 SD BIOSENSOR, Inc.
11.5.1 SD BIOSENSOR, Inc. Corporation Information
11.5.2 SD BIOSENSOR, Inc. Business Overview
11.5.3 SD BIOSENSOR, Inc. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.5.4 SD BIOSENSOR, Inc. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 SD BIOSENSOR, Inc. Point-of-Care HbA1c Test Cartridges Sales by Product in 2025
11.5.6 SD BIOSENSOR, Inc. Point-of-Care HbA1c Test Cartridges Sales by Application in 2025
11.5.7 SD BIOSENSOR, Inc. Point-of-Care HbA1c Test Cartridges Sales by Geographic Area in 2025
11.5.8 SD BIOSENSOR, Inc. Point-of-Care HbA1c Test Cartridges SWOT Analysis
11.5.9 SD BIOSENSOR, Inc. Recent Developments
11.6 HORIBA, Ltd.
11.6.1 HORIBA, Ltd. Corporation Information
11.6.2 HORIBA, Ltd. Business Overview
11.6.3 HORIBA, Ltd. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.6.4 HORIBA, Ltd. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 HORIBA, Ltd. Recent Developments
11.7 Nova Biomedical Corporation
11.7.1 Nova Biomedical Corporation Corporation Information
11.7.2 Nova Biomedical Corporation Business Overview
11.7.3 Nova Biomedical Corporation Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.7.4 Nova Biomedical Corporation Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Nova Biomedical Corporation Recent Developments
11.8 i-SENS, Inc.
11.8.1 i-SENS, Inc. Corporation Information
11.8.2 i-SENS, Inc. Business Overview
11.8.3 i-SENS, Inc. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.8.4 i-SENS, Inc. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 i-SENS, Inc. Recent Developments
11.9 Guangzhou Wondfo Biotech Co., Ltd.
11.9.1 Guangzhou Wondfo Biotech Co., Ltd. Corporation Information
11.9.2 Guangzhou Wondfo Biotech Co., Ltd. Business Overview
11.9.3 Guangzhou Wondfo Biotech Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.9.4 Guangzhou Wondfo Biotech Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Guangzhou Wondfo Biotech Co., Ltd. Recent Developments
11.10 Getein Biotech, Inc.
11.10.1 Getein Biotech, Inc. Corporation Information
11.10.2 Getein Biotech, Inc. Business Overview
11.10.3 Getein Biotech, Inc. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.10.4 Getein Biotech, Inc. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Getein Biotech, Inc. Recent Developments
11.11 Zhejiang Orient Gene Biotech Co., Ltd.
11.11.1 Zhejiang Orient Gene Biotech Co., Ltd. Corporation Information
11.11.2 Zhejiang Orient Gene Biotech Co., Ltd. Business Overview
11.11.3 Zhejiang Orient Gene Biotech Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.11.4 Zhejiang Orient Gene Biotech Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Zhejiang Orient Gene Biotech Co., Ltd. Recent Developments
11.12 Zybio Inc.
11.12.1 Zybio Inc. Corporation Information
11.12.2 Zybio Inc. Business Overview
11.12.3 Zybio Inc. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.12.4 Zybio Inc. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Zybio Inc. Recent Developments
11.13 Boditech Med Inc.
11.13.1 Boditech Med Inc. Corporation Information
11.13.2 Boditech Med Inc. Business Overview
11.13.3 Boditech Med Inc. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.13.4 Boditech Med Inc. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Boditech Med Inc. Recent Developments
11.14 OSANG healthcare Co., Ltd.
11.14.1 OSANG healthcare Co., Ltd. Corporation Information
11.14.2 OSANG healthcare Co., Ltd. Business Overview
11.14.3 OSANG healthcare Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.14.4 OSANG healthcare Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 OSANG healthcare Co., Ltd. Recent Developments
11.15 GC Medical Science Corporation
11.15.1 GC Medical Science Corporation Corporation Information
11.15.2 GC Medical Science Corporation Business Overview
11.15.3 GC Medical Science Corporation Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.15.4 GC Medical Science Corporation Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 GC Medical Science Corporation Recent Developments
11.16 EKF-diagnostic GmbH
11.16.1 EKF-diagnostic GmbH Corporation Information
11.16.2 EKF-diagnostic GmbH Business Overview
11.16.3 EKF-diagnostic GmbH Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.16.4 EKF-diagnostic GmbH Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 EKF-diagnostic GmbH Recent Developments
11.17 TaiDoc Technology Corporation
11.17.1 TaiDoc Technology Corporation Corporation Information
11.17.2 TaiDoc Technology Corporation Business Overview
11.17.3 TaiDoc Technology Corporation Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.17.4 TaiDoc Technology Corporation Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 TaiDoc Technology Corporation Recent Developments
11.18 Apex Biotechnology Corp.
11.18.1 Apex Biotechnology Corp. Corporation Information
11.18.2 Apex Biotechnology Corp. Business Overview
11.18.3 Apex Biotechnology Corp. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.18.4 Apex Biotechnology Corp. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Apex Biotechnology Corp. Recent Developments
11.19 Goldsite Diagnostics Inc.
11.19.1 Goldsite Diagnostics Inc. Corporation Information
11.19.2 Goldsite Diagnostics Inc. Business Overview
11.19.3 Goldsite Diagnostics Inc. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.19.4 Goldsite Diagnostics Inc. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Goldsite Diagnostics Inc. Recent Developments
11.20 Wuxi BioHermes Bio&Medical Technology Co., Ltd.
11.20.1 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Corporation Information
11.20.2 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Business Overview
11.20.3 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.20.4 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Recent Developments
11.21 Xiamen Biotime Biotechnology Co., Ltd.
11.21.1 Xiamen Biotime Biotechnology Co., Ltd. Corporation Information
11.21.2 Xiamen Biotime Biotechnology Co., Ltd. Business Overview
11.21.3 Xiamen Biotime Biotechnology Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.21.4 Xiamen Biotime Biotechnology Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 Xiamen Biotime Biotechnology Co., Ltd. Recent Developments
11.22 Labnovation Technologies, Inc.
11.22.1 Labnovation Technologies, Inc. Corporation Information
11.22.2 Labnovation Technologies, Inc. Business Overview
11.22.3 Labnovation Technologies, Inc. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.22.4 Labnovation Technologies, Inc. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 Labnovation Technologies, Inc. Recent Developments
11.23 AEHEALTH LIMITED
11.23.1 AEHEALTH LIMITED Corporation Information
11.23.2 AEHEALTH LIMITED Business Overview
11.23.3 AEHEALTH LIMITED Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.23.4 AEHEALTH LIMITED Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.23.5 AEHEALTH LIMITED Recent Developments
11.24 J. Mitra & Co. Pvt. Ltd.
11.24.1 J. Mitra & Co. Pvt. Ltd. Corporation Information
11.24.2 J. Mitra & Co. Pvt. Ltd. Business Overview
11.24.3 J. Mitra & Co. Pvt. Ltd. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.24.4 J. Mitra & Co. Pvt. Ltd. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.24.5 J. Mitra & Co. Pvt. Ltd. Recent Developments
11.25 Anbio Xiamen Biotechnology Co., Ltd.
11.25.1 Anbio Xiamen Biotechnology Co., Ltd. Corporation Information
11.25.2 Anbio Xiamen Biotechnology Co., Ltd. Business Overview
11.25.3 Anbio Xiamen Biotechnology Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.25.4 Anbio Xiamen Biotechnology Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.25.5 Anbio Xiamen Biotechnology Co., Ltd. Recent Developments
11.26 Skyla Corporation
11.26.1 Skyla Corporation Corporation Information
11.26.2 Skyla Corporation Business Overview
11.26.3 Skyla Corporation Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.26.4 Skyla Corporation Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.26.5 Skyla Corporation Recent Developments
11.27 DxGen Corp.
11.27.1 DxGen Corp. Corporation Information
11.27.2 DxGen Corp. Business Overview
11.27.3 DxGen Corp. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.27.4 DxGen Corp. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.27.5 DxGen Corp. Recent Developments
11.28 SAKAE Corporation
11.28.1 SAKAE Corporation Corporation Information
11.28.2 SAKAE Corporation Business Overview
11.28.3 SAKAE Corporation Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.28.4 SAKAE Corporation Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.28.5 SAKAE Corporation Recent Developments
11.29 EMPECS Medical Device Co., Ltd.
11.29.1 EMPECS Medical Device Co., Ltd. Corporation Information
11.29.2 EMPECS Medical Device Co., Ltd. Business Overview
11.29.3 EMPECS Medical Device Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.29.4 EMPECS Medical Device Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.29.5 EMPECS Medical Device Co., Ltd. Recent Developments
11.30 EUROLyser Diagnostica GmbH
11.30.1 EUROLyser Diagnostica GmbH Corporation Information
11.30.2 EUROLyser Diagnostica GmbH Business Overview
11.30.3 EUROLyser Diagnostica GmbH Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.30.4 EUROLyser Diagnostica GmbH Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.30.5 EUROLyser Diagnostica GmbH Recent Developments
11.31 TASCOM Co., Ltd.
11.31.1 TASCOM Co., Ltd. Corporation Information
11.31.2 TASCOM Co., Ltd. Business Overview
11.31.3 TASCOM Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.31.4 TASCOM Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.31.5 TASCOM Co., Ltd. Recent Developments
11.32 CareforU Co., Ltd.
11.32.1 CareforU Co., Ltd. Corporation Information
11.32.2 CareforU Co., Ltd. Business Overview
11.32.3 CareforU Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.32.4 CareforU Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.32.5 CareforU Co., Ltd. Recent Developments
11.33 Dr. Müller Gerätebau GmbH
11.33.1 Dr. Müller Gerätebau GmbH Corporation Information
11.33.2 Dr. Müller Gerätebau GmbH Business Overview
11.33.3 Dr. Müller Gerätebau GmbH Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.33.4 Dr. Müller Gerätebau GmbH Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.33.5 Dr. Müller Gerätebau GmbH Recent Developments
11.34 Nanjing Vazyme Medical Technology Co., Ltd.
11.34.1 Nanjing Vazyme Medical Technology Co., Ltd. Corporation Information
11.34.2 Nanjing Vazyme Medical Technology Co., Ltd. Business Overview
11.34.3 Nanjing Vazyme Medical Technology Co., Ltd. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.34.4 Nanjing Vazyme Medical Technology Co., Ltd. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.34.5 Nanjing Vazyme Medical Technology Co., Ltd. Recent Developments
11.35 Vitrosens Biyoteknoloji A.Ş.
11.35.1 Vitrosens Biyoteknoloji A.Ş. Corporation Information
11.35.2 Vitrosens Biyoteknoloji A.Ş. Business Overview
11.35.3 Vitrosens Biyoteknoloji A.Ş. Point-of-Care HbA1c Test Cartridges Product Models, Descriptions and Specifications
11.35.4 Vitrosens Biyoteknoloji A.Ş. Point-of-Care HbA1c Test Cartridges Sales, Price, Revenue and Gross Margin (2021-2026)
11.35.5 Vitrosens Biyoteknoloji A.Ş. Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Point-of-Care HbA1c Test Cartridges Industry Chain
12.2 Point-of-Care HbA1c Test Cartridges Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Point-of-Care HbA1c Test Cartridges Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Point-of-Care HbA1c Test Cartridges Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Point-of-Care HbA1c Test Cartridges Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Point-of-Care HbA1c Test Cartridges Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Point-of-Care HbA1c Test Cartridges Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Point-of-Care HbA1c Test Cartridges Market Size Growth Rate by Analyzer Platform Scope, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Point-of-Care HbA1c Test Cartridges Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Point-of-Care HbA1c Test Cartridges Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Point-of-Care HbA1c Test Cartridges Revenue by Region (US$ Million), 2021-2026
Table 6. Global Point-of-Care HbA1c Test Cartridges Revenue by Region (US$ Million), 2027-2032
Table 7. Global Point-of-Care HbA1c Test Cartridges Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 8. Global Point-of-Care HbA1c Test Cartridges Sales by Region (K Units), 2021-2026
Table 9. Global Point-of-Care HbA1c Test Cartridges Sales by Region (K Units), 2027-2032
Table 10. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 11. Global Point-of-Care HbA1c Test Cartridges Sales by Manufacturers (K Units), 2021-2026
Table 12. Global Point-of-Care HbA1c Test Cartridges Sales Share by Manufacturers (2021-2026)
Table 13. Global Point-of-Care HbA1c Test Cartridges Revenue by Manufacturers (US$ Million), 2021-2026
Table 14. Global Point-of-Care HbA1c Test Cartridges Revenue-Based Market Share by Manufacturers (2021-2026)
Table 15. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 16. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Point-of-Care HbA1c Test Cartridges Revenue, 2025
Table 17. Global Point-of-Care HbA1c Test Cartridges Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 18. Global Point-of-Care HbA1c Test Cartridges Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 19. Key Manufacturers Point-of-Care HbA1c Test Cartridges Manufacturing Base and Headquarters
Table 20. Global Point-of-Care HbA1c Test Cartridges Market Concentration Ratio (CR5)
Table 21. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 22. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 23. Global Point-of-Care HbA1c Test Cartridges Sales Volume by Type (K Units), 2021-2026
Table 24. Global Point-of-Care HbA1c Test Cartridges Sales Volume by Type (K Units), 2027-2032
Table 25. Global Point-of-Care HbA1c Test Cartridges Revenue by Type (US$ Million), 2021-2026
Table 26. Global Point-of-Care HbA1c Test Cartridges Revenue by Type (US$ Million), 2027-2032
Table 27. Global Point-of-Care HbA1c Test Cartridges Sales Volume by Analyzer Platform Scope (K Units), 2021-2026
Table 28. Global Point-of-Care HbA1c Test Cartridges Sales Volume by Analyzer Platform Scope (K Units), 2027-2032
Table 29. Global Point-of-Care HbA1c Test Cartridges Revenue by Analyzer Platform Scope (US$ Million), 2021-2026
Table 30. Global Point-of-Care HbA1c Test Cartridges Revenue by Analyzer Platform Scope (US$ Million), 2027-2032
Table 31. Technical Specifications by Key Product Type
Table 32. Global Point-of-Care HbA1c Test Cartridges Sales by Application (K Units), 2021-2026
Table 33. Global Point-of-Care HbA1c Test Cartridges Sales by Application (K Units), 2027-2032
Table 34. Point-of-Care HbA1c Test Cartridges High-Growth Sectors Demand CAGR (2026-2032)
Table 35. Global Point-of-Care HbA1c Test Cartridges Revenue by Application (US$ Million), 2021-2026
Table 36. Global Point-of-Care HbA1c Test Cartridges Revenue by Application (US$ Million), 2027-2032
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Point-of-Care HbA1c Test Cartridges Growth Accelerators and Market Barriers
Table 40. North America Point-of-Care HbA1c Test Cartridges Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 41. North America Point-of-Care HbA1c Test Cartridges Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 42. Europe Point-of-Care HbA1c Test Cartridges Growth Accelerators and Market Barriers
Table 43. Europe Point-of-Care HbA1c Test Cartridges Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Europe Point-of-Care HbA1c Test Cartridges Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 45. Asia-Pacific Point-of-Care HbA1c Test Cartridges Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Asia-Pacific Point-of-Care HbA1c Test Cartridges Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Asia-Pacific Point-of-Care HbA1c Test Cartridges Growth Accelerators and Market Barriers
Table 48. Southeast Asia Point-of-Care HbA1c Test Cartridges Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Central and South America Point-of-Care HbA1c Test Cartridges Investment Opportunities and Key Challenges
Table 50. Central and South America Point-of-Care HbA1c Test Cartridges Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 51. Middle East and Africa Point-of-Care HbA1c Test Cartridges Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Point-of-Care HbA1c Test Cartridges Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 53. Abbott Diagnostics Technologies AS Corporation Information
Table 54. Abbott Diagnostics Technologies AS Description and Major Businesses
Table 55. Abbott Diagnostics Technologies AS Product Models, Descriptions and Specifications
Table 56. Abbott Diagnostics Technologies AS Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 57. Abbott Diagnostics Technologies AS Sales Value Proportion by Product in 2025
Table 58. Abbott Diagnostics Technologies AS Sales Value Proportion by Application in 2025
Table 59. Abbott Diagnostics Technologies AS Sales Value Proportion by Geographic Area in 2025
Table 60. Abbott Diagnostics Technologies AS Point-of-Care HbA1c Test Cartridges SWOT Analysis
Table 61. Abbott Diagnostics Technologies AS Recent Developments
Table 62. Siemens Healthcare Diagnostics Inc. Corporation Information
Table 63. Siemens Healthcare Diagnostics Inc. Description and Major Businesses
Table 64. Siemens Healthcare Diagnostics Inc. Product Models, Descriptions and Specifications
Table 65. Siemens Healthcare Diagnostics Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. Siemens Healthcare Diagnostics Inc. Sales Value Proportion by Product in 2025
Table 67. Siemens Healthcare Diagnostics Inc. Sales Value Proportion by Application in 2025
Table 68. Siemens Healthcare Diagnostics Inc. Sales Value Proportion by Geographic Area in 2025
Table 69. Siemens Healthcare Diagnostics Inc. Point-of-Care HbA1c Test Cartridges SWOT Analysis
Table 70. Siemens Healthcare Diagnostics Inc. Recent Developments
Table 71. ACON Laboratories, Inc. Corporation Information
Table 72. ACON Laboratories, Inc. Description and Major Businesses
Table 73. ACON Laboratories, Inc. Product Models, Descriptions and Specifications
Table 74. ACON Laboratories, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. ACON Laboratories, Inc. Sales Value Proportion by Product in 2025
Table 76. ACON Laboratories, Inc. Sales Value Proportion by Application in 2025
Table 77. ACON Laboratories, Inc. Sales Value Proportion by Geographic Area in 2025
Table 78. ACON Laboratories, Inc. Point-of-Care HbA1c Test Cartridges SWOT Analysis
Table 79. ACON Laboratories, Inc. Recent Developments
Table 80. Changsha Sinocare Inc. Corporation Information
Table 81. Changsha Sinocare Inc. Description and Major Businesses
Table 82. Changsha Sinocare Inc. Product Models, Descriptions and Specifications
Table 83. Changsha Sinocare Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Changsha Sinocare Inc. Sales Value Proportion by Product in 2025
Table 85. Changsha Sinocare Inc. Sales Value Proportion by Application in 2025
Table 86. Changsha Sinocare Inc. Sales Value Proportion by Geographic Area in 2025
Table 87. Changsha Sinocare Inc. Point-of-Care HbA1c Test Cartridges SWOT Analysis
Table 88. Changsha Sinocare Inc. Recent Developments
Table 89. SD BIOSENSOR, Inc. Corporation Information
Table 90. SD BIOSENSOR, Inc. Description and Major Businesses
Table 91. SD BIOSENSOR, Inc. Product Models, Descriptions and Specifications
Table 92. SD BIOSENSOR, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. SD BIOSENSOR, Inc. Sales Value Proportion by Product in 2025
Table 94. SD BIOSENSOR, Inc. Sales Value Proportion by Application in 2025
Table 95. SD BIOSENSOR, Inc. Sales Value Proportion by Geographic Area in 2025
Table 96. SD BIOSENSOR, Inc. Point-of-Care HbA1c Test Cartridges SWOT Analysis
Table 97. SD BIOSENSOR, Inc. Recent Developments
Table 98. HORIBA, Ltd. Corporation Information
Table 99. HORIBA, Ltd. Description and Major Businesses
Table 100. HORIBA, Ltd. Product Models, Descriptions and Specifications
Table 101. HORIBA, Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. HORIBA, Ltd. Recent Developments
Table 103. Nova Biomedical Corporation Corporation Information
Table 104. Nova Biomedical Corporation Description and Major Businesses
Table 105. Nova Biomedical Corporation Product Models, Descriptions and Specifications
Table 106. Nova Biomedical Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Nova Biomedical Corporation Recent Developments
Table 108. i-SENS, Inc. Corporation Information
Table 109. i-SENS, Inc. Description and Major Businesses
Table 110. i-SENS, Inc. Product Models, Descriptions and Specifications
Table 111. i-SENS, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. i-SENS, Inc. Recent Developments
Table 113. Guangzhou Wondfo Biotech Co., Ltd. Corporation Information
Table 114. Guangzhou Wondfo Biotech Co., Ltd. Description and Major Businesses
Table 115. Guangzhou Wondfo Biotech Co., Ltd. Product Models, Descriptions and Specifications
Table 116. Guangzhou Wondfo Biotech Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Guangzhou Wondfo Biotech Co., Ltd. Recent Developments
Table 118. Getein Biotech, Inc. Corporation Information
Table 119. Getein Biotech, Inc. Description and Major Businesses
Table 120. Getein Biotech, Inc. Product Models, Descriptions and Specifications
Table 121. Getein Biotech, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Getein Biotech, Inc. Recent Developments
Table 123. Zhejiang Orient Gene Biotech Co., Ltd. Corporation Information
Table 124. Zhejiang Orient Gene Biotech Co., Ltd. Description and Major Businesses
Table 125. Zhejiang Orient Gene Biotech Co., Ltd. Product Models, Descriptions and Specifications
Table 126. Zhejiang Orient Gene Biotech Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Zhejiang Orient Gene Biotech Co., Ltd. Recent Developments
Table 128. Zybio Inc. Corporation Information
Table 129. Zybio Inc. Description and Major Businesses
Table 130. Zybio Inc. Product Models, Descriptions and Specifications
Table 131. Zybio Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Zybio Inc. Recent Developments
Table 133. Boditech Med Inc. Corporation Information
Table 134. Boditech Med Inc. Description and Major Businesses
Table 135. Boditech Med Inc. Product Models, Descriptions and Specifications
Table 136. Boditech Med Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Boditech Med Inc. Recent Developments
Table 138. OSANG healthcare Co., Ltd. Corporation Information
Table 139. OSANG healthcare Co., Ltd. Description and Major Businesses
Table 140. OSANG healthcare Co., Ltd. Product Models, Descriptions and Specifications
Table 141. OSANG healthcare Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. OSANG healthcare Co., Ltd. Recent Developments
Table 143. GC Medical Science Corporation Corporation Information
Table 144. GC Medical Science Corporation Description and Major Businesses
Table 145. GC Medical Science Corporation Product Models, Descriptions and Specifications
Table 146. GC Medical Science Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. GC Medical Science Corporation Recent Developments
Table 148. EKF-diagnostic GmbH Corporation Information
Table 149. EKF-diagnostic GmbH Description and Major Businesses
Table 150. EKF-diagnostic GmbH Product Models, Descriptions and Specifications
Table 151. EKF-diagnostic GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. EKF-diagnostic GmbH Recent Developments
Table 153. TaiDoc Technology Corporation Corporation Information
Table 154. TaiDoc Technology Corporation Description and Major Businesses
Table 155. TaiDoc Technology Corporation Product Models, Descriptions and Specifications
Table 156. TaiDoc Technology Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. TaiDoc Technology Corporation Recent Developments
Table 158. Apex Biotechnology Corp. Corporation Information
Table 159. Apex Biotechnology Corp. Description and Major Businesses
Table 160. Apex Biotechnology Corp. Product Models, Descriptions and Specifications
Table 161. Apex Biotechnology Corp. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Apex Biotechnology Corp. Recent Developments
Table 163. Goldsite Diagnostics Inc. Corporation Information
Table 164. Goldsite Diagnostics Inc. Description and Major Businesses
Table 165. Goldsite Diagnostics Inc. Product Models, Descriptions and Specifications
Table 166. Goldsite Diagnostics Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Goldsite Diagnostics Inc. Recent Developments
Table 168. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Corporation Information
Table 169. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Description and Major Businesses
Table 170. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 171. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Recent Developments
Table 173. Xiamen Biotime Biotechnology Co., Ltd. Corporation Information
Table 174. Xiamen Biotime Biotechnology Co., Ltd. Description and Major Businesses
Table 175. Xiamen Biotime Biotechnology Co., Ltd. Product Models, Descriptions and Specifications
Table 176. Xiamen Biotime Biotechnology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Xiamen Biotime Biotechnology Co., Ltd. Recent Developments
Table 178. Labnovation Technologies, Inc. Corporation Information
Table 179. Labnovation Technologies, Inc. Description and Major Businesses
Table 180. Labnovation Technologies, Inc. Product Models, Descriptions and Specifications
Table 181. Labnovation Technologies, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. Labnovation Technologies, Inc. Recent Developments
Table 183. AEHEALTH LIMITED Corporation Information
Table 184. AEHEALTH LIMITED Description and Major Businesses
Table 185. AEHEALTH LIMITED Product Models, Descriptions and Specifications
Table 186. AEHEALTH LIMITED Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. AEHEALTH LIMITED Recent Developments
Table 188. J. Mitra & Co. Pvt. Ltd. Corporation Information
Table 189. J. Mitra & Co. Pvt. Ltd. Description and Major Businesses
Table 190. J. Mitra & Co. Pvt. Ltd. Product Models, Descriptions and Specifications
Table 191. J. Mitra & Co. Pvt. Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. J. Mitra & Co. Pvt. Ltd. Recent Developments
Table 193. Anbio Xiamen Biotechnology Co., Ltd. Corporation Information
Table 194. Anbio Xiamen Biotechnology Co., Ltd. Description and Major Businesses
Table 195. Anbio Xiamen Biotechnology Co., Ltd. Product Models, Descriptions and Specifications
Table 196. Anbio Xiamen Biotechnology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 197. Anbio Xiamen Biotechnology Co., Ltd. Recent Developments
Table 198. Skyla Corporation Corporation Information
Table 199. Skyla Corporation Description and Major Businesses
Table 200. Skyla Corporation Product Models, Descriptions and Specifications
Table 201. Skyla Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 202. Skyla Corporation Recent Developments
Table 203. DxGen Corp. Corporation Information
Table 204. DxGen Corp. Description and Major Businesses
Table 205. DxGen Corp. Product Models, Descriptions and Specifications
Table 206. DxGen Corp. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 207. DxGen Corp. Recent Developments
Table 208. SAKAE Corporation Corporation Information
Table 209. SAKAE Corporation Description and Major Businesses
Table 210. SAKAE Corporation Product Models, Descriptions and Specifications
Table 211. SAKAE Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 212. SAKAE Corporation Recent Developments
Table 213. EMPECS Medical Device Co., Ltd. Corporation Information
Table 214. EMPECS Medical Device Co., Ltd. Description and Major Businesses
Table 215. EMPECS Medical Device Co., Ltd. Product Models, Descriptions and Specifications
Table 216. EMPECS Medical Device Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 217. EMPECS Medical Device Co., Ltd. Recent Developments
Table 218. EUROLyser Diagnostica GmbH Corporation Information
Table 219. EUROLyser Diagnostica GmbH Description and Major Businesses
Table 220. EUROLyser Diagnostica GmbH Product Models, Descriptions and Specifications
Table 221. EUROLyser Diagnostica GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 222. EUROLyser Diagnostica GmbH Recent Developments
Table 223. TASCOM Co., Ltd. Corporation Information
Table 224. TASCOM Co., Ltd. Description and Major Businesses
Table 225. TASCOM Co., Ltd. Product Models, Descriptions and Specifications
Table 226. TASCOM Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 227. TASCOM Co., Ltd. Recent Developments
Table 228. CareforU Co., Ltd. Corporation Information
Table 229. CareforU Co., Ltd. Description and Major Businesses
Table 230. CareforU Co., Ltd. Product Models, Descriptions and Specifications
Table 231. CareforU Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 232. CareforU Co., Ltd. Recent Developments
Table 233. Dr. Müller Gerätebau GmbH Corporation Information
Table 234. Dr. Müller Gerätebau GmbH Description and Major Businesses
Table 235. Dr. Müller Gerätebau GmbH Product Models, Descriptions and Specifications
Table 236. Dr. Müller Gerätebau GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 237. Dr. Müller Gerätebau GmbH Recent Developments
Table 238. Nanjing Vazyme Medical Technology Co., Ltd. Corporation Information
Table 239. Nanjing Vazyme Medical Technology Co., Ltd. Description and Major Businesses
Table 240. Nanjing Vazyme Medical Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 241. Nanjing Vazyme Medical Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 242. Nanjing Vazyme Medical Technology Co., Ltd. Recent Developments
Table 243. Vitrosens Biyoteknoloji A.Ş. Corporation Information
Table 244. Vitrosens Biyoteknoloji A.Ş. Description and Major Businesses
Table 245. Vitrosens Biyoteknoloji A.Ş. Product Models, Descriptions and Specifications
Table 246. Vitrosens Biyoteknoloji A.Ş. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 247. Vitrosens Biyoteknoloji A.Ş. Recent Developments
Table 248. Key Raw Materials Distribution
Table 249. Raw Materials Key Suppliers
Table 250. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 251. Milestones in Production Technology Evolution
Table 252. Distributors List
Table 253. Market Trends and Market Evolution
Table 254. Market Drivers and Opportunities
Table 255. Market Challenges, Risks, and Restraints
Table 256. Research Programs/Design for This Report
Table 257. Key Data Information from Secondary Sources
Table 258. Key Data Information from Primary Sources

List of Figures
Figure 1. Point-of-Care HbA1c Test Cartridges Product Picture
Figure 2. Global Point-of-Care HbA1c Test Cartridges Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Boronate Affinity HbA1c Cartridges Product Picture
Figure 4. Antibody Agglutination HbA1c Cartridges Product Picture
Figure 5. Fluorescence Immunoassay HbA1c Cartridges Product Picture
Figure 6. Other Product Picture
Figure 7. Global Point-of-Care HbA1c Test Cartridges Market Size Growth Rate by Analyzer Platform Scope, 2021 vs 2025 vs 2032 (US$ Million)
Figure 8. Dedicated HbA1c Platform Cartridges Product Picture
Figure 9. Multi-Assay POCT Platform Cartridges Product Picture
Figure 10. Other Product Picture
Figure 11. Global Point-of-Care HbA1c Test Cartridges Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 12. Primary Care Clinics
Figure 13. Diabetes Specialty Clinics
Figure 14. Hospital Outpatient Departments
Figure 15. Community Health Centers
Figure 16. Pharmacies
Figure 17. Long-Term Care Facilities
Figure 18. Other
Figure 19. Point-of-Care HbA1c Test Cartridges Report Years Considered
Figure 20. Global Point-of-Care HbA1c Test Cartridges Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 22. Global Point-of-Care HbA1c Test Cartridges Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 23. Global Point-of-Care HbA1c Test Cartridges Revenue-Based Market Share by Region (2021-2032)
Figure 24. Global Point-of-Care HbA1c Test Cartridges Sales (K Units), 2021-2032
Figure 25. Global Point-of-Care HbA1c Test Cartridges Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 26. Global Point-of-Care HbA1c Test Cartridges Sales Market Share by Region (2021-2032)
Figure 27. Top 5 and Top 10 Manufacturers Point-of-Care HbA1c Test Cartridges Sales Volume Market Share in 2025
Figure 28. Global Point-of-Care HbA1c Test Cartridges Revenue-Based Market Share Ranking (2025)
Figure 29. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 30. Boronate Affinity HbA1c Cartridges Revenue-Based Market Share by Manufacturer in 2025
Figure 31. Antibody Agglutination HbA1c Cartridges Revenue-Based Market Share by Manufacturer in 2025
Figure 32. Fluorescence Immunoassay HbA1c Cartridges Revenue-Based Market Share by Manufacturer in 2025
Figure 33. Other Revenue-Based Market Share by Manufacturer in 2025
Figure 34. Global Point-of-Care HbA1c Test Cartridges Sales Volume-Based Market Share by Type (2021-2032)
Figure 35. Global Point-of-Care HbA1c Test Cartridges Revenue-Based Market Share by Type (2021-2032)
Figure 36. Global Point-of-Care HbA1c Test Cartridges ASP by Type (US$/Unit), 2021-2032
Figure 37. Global Point-of-Care HbA1c Test Cartridges Sales Volume-Based Market Share by Analyzer Platform Scope (2021-2032)
Figure 38. Global Point-of-Care HbA1c Test Cartridges Revenue-Based Market Share by Analyzer Platform Scope (2021-2032)
Figure 39. Global Point-of-Care HbA1c Test Cartridges ASP by Analyzer Platform Scope (US$/Unit), 2021-2032
Figure 40. Global Point-of-Care HbA1c Test Cartridges Revenue-Based Market Share (2021-2032)
Figure 41. Global Point-of-Care HbA1c Test Cartridges Sales Market Share by Application (2021-2032)
Figure 42. Global Point-of-Care HbA1c Test Cartridges Revenue-Based Market Share by Application (2021-2032)
Figure 43. Global Point-of-Care HbA1c Test Cartridges ASP by Application (US$/Unit), 2021-2032
Figure 44. North America Point-of-Care HbA1c Test Cartridges Sales YoY (K Units), 2021-2032
Figure 45. North America Point-of-Care HbA1c Test Cartridges Revenue YoY (US$ Million), 2021-2032
Figure 46. North America Top 5 Manufacturers Point-of-Care HbA1c Test Cartridges Sales Revenue (US$ Million) in 2025
Figure 47. North America Point-of-Care HbA1c Test Cartridges Sales Volume (K Units) by Application (2021-2032)
Figure 48. North America Point-of-Care HbA1c Test Cartridges Sales Revenue (US$ Million) by Application (2021-2032)
Figure 49. US Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 50. Canada Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 51. Mexico Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 52. Europe Point-of-Care HbA1c Test Cartridges Sales YoY (K Units), 2021-2032
Figure 53. Europe Point-of-Care HbA1c Test Cartridges Revenue YoY (US$ Million), 2021-2032
Figure 54. Europe Top 5 Manufacturers Point-of-Care HbA1c Test Cartridges Sales Revenue (US$ Million) in 2025
Figure 55. Europe Point-of-Care HbA1c Test Cartridges Sales Volume (K Units) by Application (2021-2032)
Figure 56. Europe Point-of-Care HbA1c Test Cartridges Sales Revenue (US$ Million) by Application (2021-2032)
Figure 57. Germany Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 58. France Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 59. U.K. Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 60. Italy Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 61. Russia Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 62. Asia-Pacific Point-of-Care HbA1c Test Cartridges Sales YoY (K Units), 2021-2032
Figure 63. Asia-Pacific Point-of-Care HbA1c Test Cartridges Revenue YoY (US$ Million), 2021-2032
Figure 64. Asia-Pacific Top 8 Manufacturers Point-of-Care HbA1c Test Cartridges Sales Revenue (US$ Million) in 2025
Figure 65. Asia-Pacific Point-of-Care HbA1c Test Cartridges Sales Volume (K Units) by Application (2021-2032)
Figure 66. Asia-Pacific Point-of-Care HbA1c Test Cartridges Sales Revenue (US$ Million) by Application (2021-2032)
Figure 67. Indonesia Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 68. Japan Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 69. South Korea Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 70. China Taiwan Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 71. India Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 72. Central and South America Point-of-Care HbA1c Test Cartridges Sales YoY (K Units), 2021-2032
Figure 73. Central and South America Point-of-Care HbA1c Test Cartridges Revenue YoY (US$ Million), 2021-2032
Figure 74. Central and South America Top 5 Manufacturers Point-of-Care HbA1c Test Cartridges Sales Revenue (US$ Million) in 2025
Figure 75. Central and South America Point-of-Care HbA1c Test Cartridges Sales Volume (K Units) by Application (2021-2032)
Figure 76. Central and South America Point-of-Care HbA1c Test Cartridges Sales Revenue (US$ Million) by Application (2021-2032)
Figure 77. Brazil Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 78. Argentina Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 79. Middle East, and Africa Point-of-Care HbA1c Test Cartridges Sales YoY (K Units), 2021-2032
Figure 80. Middle East and Africa Point-of-Care HbA1c Test Cartridges Revenue YoY (US$ Million), 2021-2032
Figure 81. Middle East and Africa Top 5 Manufacturers Point-of-Care HbA1c Test Cartridges Sales Revenue (US$ Million) in 2025
Figure 82. Middle East and Africa Point-of-Care HbA1c Test Cartridges Sales Volume (K Units) by Application (2021-2032)
Figure 83. Middle East and Africa Point-of-Care HbA1c Test Cartridges Sales Revenue (US$ Million) by Application (2021-2032)
Figure 84. GCC Countries Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 85. Turkey Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 86. Egypt Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 87. South Africa Point-of-Care HbA1c Test Cartridges Revenue (US$ Million), 2021-2032
Figure 88. Point-of-Care HbA1c Test Cartridges Industry Chain Mapping
Figure 89. Regional Point-of-Care HbA1c Test Cartridges Manufacturing Base Distribution (%)
Figure 90. Global Point-of-Care HbA1c Test Cartridges Production Market Share by Region (2021-2032)
Figure 91. Point-of-Care HbA1c Test Cartridges Production Process
Figure 92. Regional Point-of-Care HbA1c Test Cartridges Production Cost Structure
Figure 93. Channels of Distribution (Direct Vs Distribution)